Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Nasopharyngeal Carcinoma 12Esophageal Squamous Cell Carcinoma 7Esophageal Neoplasms 6Squamous Cell Carcinoma of Head and Neck 3Carcinoma, Squamous Cell 2Carcinoma, Non-Small-Cell Lung 2Uterine Cervical Neoplasms 1Resectable Lung Non-Small Cell Carcinoma 1Recurrence 1Neoplasms 1Lymphoma 1Immunotherapy Esophagus Cancer 1Hypopharyngeal Neoplasms 1Hepatic Artery Infusion 1Head and Neck Neoplasms 1Central Nervous System Neoplasms 1Advanced Non-squamous Non-Small-Cell Lung Cancer 1

Interventions

Cyclophosphamide 115Dexamethasone 70fludarabine phosphate 57Cytarabine 56fludarabine 52Rituximab 51Peripheral Blood Stem Cell Transplantation 40Etoposide 40Gemcitabine 39Lenalidomide 38pembrolizumab 33Radiotherapy 33Busulfan 33Filgrastim 32Carboplatin 31Methotrexate 30Cyclosporine 29Cisplatin 29Bortezomib 29Mycophenolic Acid 28Melphalan 28venetoclax 27Paclitaxel 26Whole-Body Irradiation 24Antilymphocyte Serum 23Temozolomide 22Granulocyte Colony-Stimulating Factor 20Calcium Dobesilate 20Bevacizumab 20Tacrolimus 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Recurrence × nedaplatin × Clear all
NCT02789189 2019-09-06

Nedaplatin Combined With Gemcitabine in the Treatment of Recurrent and/or Metastatic Nasopharyngeal Carcinoma : a Single Arm and Phase â…¡ Clinical Trail

Sun Yat-sen University

Phase 2 Terminated
60 enrolled
Head & Neck

Nasopharyngeal Carcinoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡